Evotec SE
Close on Oct 19, 2026
About Evotec
Pharmaceutical Preparations, SIC 2834
Evotec operates as a drug discovery and development partner providing research services and solutions to the pharmaceutical and biotechnology industries. The company conducts collaborative research and development across two principal operating segments: Shared R&D and Just - Evotec Biologics. Its offerings include fee-based research, full-time equivalent research payments, integrated data analytics platforms such as PanHunter and molecular patient databases, and technology licensing. Evotec primarily serves commercial biopharmaceutical organizations and healthcare partners.
The company operates across multiple international markets, maintaining key operating entities and facilities across Germany, the United States, the United Kingdom, France, Italy, Switzerland, Austria, and Singapore. Evotec SE coordinates these international activities and conducts its corporate affairs from its principal headquarters located in Hamburg, Germany.
Summary of the business section of Evotec's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Evotec SE
- Headquarters
- Hamburg, Germany
- Address
- Essener Bogen 7 22419
- Phone
- (494) 056-0810
- Employees
- 4,553, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- 2M
- Fiscal year ends
- December 31
- Auditor
- BDO AG Wirtschaftsprufungsgesellschaft, Frankfurt am Main, Germany
Stock & identifiers
- Ticker
- EVO
- Other tickers
- EVOTF
- Exchange
- Nasdaq
- IPO date
- Feb 5, 2004
- Shares outstanding
- 178M, Dec 31, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 4-for-1, Oct 20, 2021
- SEC CIK
- 1412558
- CUSIP
- 30050E105
- ISIN
- US30050E1055
- LEI
- 529900F9KI6OYITO9B12
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Evotec's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed 4,553 individuals worldwide (December 31, 2024: 4,827; December 31, 2023: 5,061).”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 30, 2024 | Late filing | Notification of late filing |
| May 2, 2023 | Late filing | Notification of late filing |
| Nov 1, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| Sep 23, 2021 | Name change | Name changed from Evotec AG to Evotec SE |
| Dec 30, 2010 | Deregistration | Termination of SEC registration (Form 15) |
| Nov 20, 2009 | Delisting | Notice of delisting from exchange (Form 25) |
| May 1, 2008 | Listing | Registration of securities on an exchange (Form 8-A) |
| Jan 7, 2008 | Merger | Registration of securities for a merger or exchange offer (S-4) |